Compounds > busulfan
Page last updated: 2024-10-24

busulfan and Cancer of Endometrium

busulfan has been researched along with Cancer of Endometrium in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Both busulfan treatment doses caused earlier occurrence of persistent estrus, with dose-dependence as compared to controls."5.33Reduction of primordial follicles caused by maternal treatment with busulfan promotes endometrial adenocarcinoma development in donryu rats. ( Maekawa, A; Shirota, M; Taya, K; Watanabe, G; Yoshida, M, 2005)
"Both busulfan treatment doses caused earlier occurrence of persistent estrus, with dose-dependence as compared to controls."1.33Reduction of primordial follicles caused by maternal treatment with busulfan promotes endometrial adenocarcinoma development in donryu rats. ( Maekawa, A; Shirota, M; Taya, K; Watanabe, G; Yoshida, M, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yoshida, M1
Watanabe, G1
Shirota, M1
Maekawa, A1
Taya, K1

Other Studies

1 other study available for busulfan and Cancer of Endometrium

ArticleYear
Reduction of primordial follicles caused by maternal treatment with busulfan promotes endometrial adenocarcinoma development in donryu rats.
    The Journal of reproduction and development, 2005, Volume: 51, Issue:6

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Alkylating; Atrophy; Busulfan; Endometrial Neoplasms

2005